In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci

Vancomycin-resistant enterococci (VRE) are a serious public health threat and a leading cause of healthcare-associated infections. Bacterial resistance to antibiotics recommended for the treatment of enterococcal infections complicates the management of these infections. Hence, there is a critical n...

Descripción completa

Detalles Bibliográficos
Autores principales: Abutaleb, Nader S., Elhassanny, Ahmed E.M., Flaherty, Daniel P., Seleem, Mohamed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018244/
https://www.ncbi.nlm.nih.gov/pubmed/33850651
http://dx.doi.org/10.7717/peerj.11059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018244/
https://www.ncbi.nlm.nih.gov/pubmed/33850651
http://dx.doi.org/10.7717/peerj.11059

Ejemplares similares